The Department of Defense is taking applications for its Horizon Award, which offers up to $75,000 in funding to support junior-level scientists to conduct impactful research with the mentorship of an experienced cancer researcher.
TheAmerican Association for Cancer Research has launched theAACR NextGen Grants for Transformative Cancer Research, a funding initiative to stimulate innovative research from young investigators.
The Pharmaceutical Research and Manufacturers of American Foundation launched a platform featuring resources on its competitive research grants and fellowships for young scientists.
The Myeloma Crowd Research Initiative is accepting research proposals for high-risk multiple myeloma until the end of February, through the Myeloma Crowd website. The Myeloma Crowd is a division of the CrowdCare Foundation.
The Society for Immunotherapy of Cancer, with support from Merck, is providing funding for cancer immunotherapy research through the SITC-Merck Cancer Immunotherapy Clinical Fellowship
NCI is hosting a Small Business Innovation Research Investor Forum Nov. 13 at Agilent Technologies in Santa Clara, Calif., where 28 SBIR-funded companies will present cancer therapeutics, diagnostics, and devices.
THE LEUKEMIA & LYMPHOMA SOCIETY launched a program to fund research projects focused on myeloid diseases, such as myelodysplastic syndromes and myeloproliferative neoplasms, both of which can progress to acute myeloid leukemia.
Stand Up To Cancer Canada will support two, four-year cancer research dream teams with nearly $20 million USD raised by SU2C Canada collaborators and from the charity's September telecast. The dream teams will focus their research on translational research in breast cancer and cancer stem cells.
THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCEis taking applications for its Prize for Young Investigators in Cancer Research.
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH is accepting submissions of ideas to two dream team grants: one offering $20 million for lung cancer research, and one for $6 million for ovarian cancer research.
